| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 84.812 | 85.111 | 72.543 | 102.020 | 93.937 | 89.896 | 80.842 | 58.306 | 48.675 | 23.138 |
| Total Income - EUR | 87.149 | 87.425 | 78.045 | 103.125 | 94.647 | 90.255 | 81.675 | 59.358 | 49.039 | 23.185 |
| Total Expenses - EUR | 79.690 | 83.209 | 69.953 | 42.237 | 45.455 | 47.690 | 46.753 | 47.300 | 45.112 | 24.585 |
| Gross Profit/Loss - EUR | 7.458 | 4.216 | 8.092 | 60.888 | 49.192 | 42.565 | 34.922 | 12.058 | 3.927 | -1.400 |
| Net Profit/Loss - EUR | 4.914 | 3.362 | 7.321 | 59.868 | 48.253 | 41.698 | 34.113 | 11.475 | 3.440 | -1.632 |
| Employees | 3 | 3 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Regane Labs Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 16 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 12.417 | 12.040 | 13.485 | 15.134 | 14.173 | 43.296 | 41.512 | 19.836 | 22.467 | 17.640 |
| Inventories | 237 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 12.117 | 10.526 | 13.206 | 15.029 | 11.654 | 42.431 | 40.676 | 18.788 | 22.331 | 16.263 |
| Cash | 63 | 1.514 | 279 | 105 | 2.520 | 865 | 835 | 1.049 | 136 | 1.377 |
| Shareholders Funds | -130.079 | -125.391 | -115.948 | -53.952 | -4.655 | 37.132 | 35.399 | 12.764 | 13.903 | 12.194 |
| Social Capital | 1.192 | 1.180 | 1.160 | 1.139 | 1.117 | 1.096 | 1.071 | 1.075 | 1.071 | 1.065 |
| Debts | 142.512 | 137.431 | 129.433 | 69.086 | 18.828 | 6.164 | 6.113 | 7.072 | 8.564 | 5.446 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5829 - 5829" | |||||||||
| CAEN Financial Year |
5829
|
|||||||||
Comments - Regane Labs Srl